AMER1
APC membrane recruitment protein 1
Also known as: AMER1_HUMAN, FAM123B, FLJ39827, RP11-403E24.2, WTX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JTC6
- Gene
- AMER1
- Ensembl
- ENSG00000184675
- Chromosome
- X
- Canonical length
- 1135 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nuclear bodies,Vesicles,Plasma membrane
OverviewNCBI Gene
The protein encoded by this gene upregulates trancriptional activation by the Wilms tumor protein and interacts with many other proteins, including CTNNB1, APC, AXIN1, and AXIN2. Defects in this gene are a cause of osteopathia striata with cranial sclerosis (OSCS). [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
1135 residues, UniProt reviewed canonical sequence.
>Q5JTC6|AMER1
1 METQKDEAAQ AKGAAASGST REQTAEKGAK NKAAEATEGP TSEPSSSGPG RLKKTAMKLF
61 GGKKGICTLP SFFGGGRSKG SGKGSSKKGL SKSKTHDGLS EAAHGPEDVV SEGTGFSLPL
121 PELPCQFPSS QSAHGALETG SRCKTSVAGA TEKAVAEKFP SMPKPKKGLK GFFSSIRRHR
181 KSKVTGAEQS EPGAKGPERV RARPHEHVSS APQVPCFEET FQAPRKENAN PQDAPGPKVS
241 PTPEPSPPAT EKMACKDPEK PMEACASAHV QPKPAPEASS LEEPHSPETG EKVVAGEVNP
301 PNGPVGDPLS LLFGDVTSLK SFDSLTGCGD IIAEQDMDSM TDSMASGGQR ANRDGTKRSS
361 CLVTYQGGGE EMALPDDDDE EEEEEEEVEL EEEEEEVKEE EEDDDLEYLW ETAQMYPRPN
421 MNLGYHPTTS PGHHGYMLLD PVRSYPGLAP GELLTPQSDQ QESAPNSDEG YYDSTTPGFE
481 DDSGEALGLV RRDCLPRDSY SGDALYEFYE PDDSLENSPP GDDCLYDLHG RSSEMFDPFL
541 NFEPFLSSRP PGAMETEEER LVTIQKQLLY WELRREQLEA QEARAREAHA REAHAREAYT
601 REAYGREAYA REAHTWEAHG REARTREAQA REVRCRETQV RETQARQEKP VLEYQMRPLG
661 PSVMGLAAGV SGTSQISHRG ITSAFPTTAS SEPDWRDFRP LEKRYEGTCS KKDQSTCLMQ
721 LFQSDAMFEP DMQEANFGGS PRRAYPTYSP PEDPEEEEVE KEGNATVSFS QALVEFTSNG
781 NLFSSMSCSS DSDSSFTQNL PELPPMVTFD IADVERDGEG KCEENPEFHN DEDLAASLEA
841 FELGYYHKHA FNNYHSRFYQ GLPWGVSSLP RYLGLPGLHP RPPPAAMALN RRSRSLDTAE
901 TLEMELSNSH LVQGYLESDE LQAQQEDSDE EDEEEEEGEW SRDSPLSLYT EPPGAYDWPA
961 WAPCPLPVGP GPAWISPNQL DRPSSQSPYR QATCCIPPMT MSISLSVPES RAPGESGPQL
1021 ARPSHLHLPM GPCYNLQPQA SQSMRARPRD VLLPVDEPSC SSSSGGFSPS PLPQAKPVGI
1081 THGIPQLPRV RPEHPQPQPT HYGPSSLDLS KERAEQGASL ATSYSSTAMN GNLAKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AMER1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- tongue: 14 nTPM
- ovary: 4.9 nTPM
- epididymis: 3.8 nTPM
- skeletal muscle: 3.8 nTPM
- liver: 2.7 nTPM
- esophagus: 2.6 nTPM
Single-cell type
- thymic myoid cells: 11 nCPM
- adrenal medulla cells: 11 nCPM
- epididymal efferent duct absorptive cells: 8.5 nCPM
- cholangiocytes: 6.6 nCPM
- epididymal principal cells: 6.5 nCPM
- hepatic stellate cells: 6.5 nCPM
Immune cell
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- hypothalamus: 6.6 nTPM
- cerebellum: 6.3 nTPM
- medulla oblongata: 5.9 nTPM
- basal ganglia: 5.8 nTPM
- cerebral cortex: 5.7 nTPM
- midbrain: 5.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AMER1.
Disease | AllUniProt
Conditions AMER1 is implicated in, by any mechanism.
- Osteopathia striata with cranial sclerosis (OSCS) MIM:300373
Disease | GeneticClinVar
47 pathogenic / likely-pathogenic of 658 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Osteopathia striata with cranial sclerosis
- Inborn genetic diseases
- Colorectal cancer
- Neoplasm
- AMER1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.85
- gnomAD missense Z
- -0.57
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adipose tissue development
- bone development
- mesenchymal cell differentiation involved in kidney development
- negative regulation of canonical Wnt signaling pathway
- positive regulation of canonical Wnt signaling pathway
- positive regulation of protein catabolic process
- positive regulation of protein ubiquitination
- regulation of canonical Wnt signaling pathway
- Wnt signaling pathway
Molecular functions
- beta-catenin binding
- beta-catenin destruction complex binding
- phosphatidylinositol-4,5-bisphosphate binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AMER1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AMER1 as an antibody target. Whether an autoantibody or antibody against AMER1 could matter depends on whether native AMER1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AMER1 is annotated at the cell surface, where native AMER1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AMER1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...